Bye-law 17, National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [SD7-049]

As at 7 September 2026. In force from 15 October 2022.

In National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [R1M-SGR]. This text from 15 October 2022. No other text held.

Synthetic. This instrument, its title, its number and the words of this section are generated by the register.

Cite: Bye-law 17, National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [SD7-049]. Machine: SD7-049.

Forms.—The forms specified in the Schedule shall be used for the purposes for which they are so specified, and where no form is specified for any purpose, an application, return or intimation which contains the particulars these bye-laws require shall be sufficient; Form 20-B and Form 28 shall be supplied by the Drugs Controller on payment of a fee of five hundred rupees, and a form so supplied shall bear the date on which it was supplied and shall be used within fourteen days of that date.

Defined terms in this text (0)

none

Made under this bye-law, or naming it (0)

none

Cited by (0)

none

Not held (0)

none

Duties published under this bye-law (0)

none